Revenue declined slightly to ¥759 million with a narrowed net loss of ¥109.9 million, driven by market and asset impairment pressures. Gross margin remained stable, R&D investment was robust, and cash flow stayed positive, but no dividend was declared due to negative retained earnings.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.